V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290006884 | 290008000 | null | 75.5 | Palliative (P) | 2018-03-10 | 2018-03-31 | CARBOPLATIN + RT | 2 | N | 290021215 | CETUXIMAB + CISPLATIN + FU |
| 290006885 | 290008000 | 1.7 | 79 | Adjuvant (A) | 2017-02-01 | 2017-02-07 | Capecitabine + Cisplatin | 01 | N | 290021215 | CISPLATIN |
| 290006886 | 290005231 | 1.81 | 83 | Palliative (P) | 2013-10-07 | 2013-10-22 | CETUXIMAB | N | N | 290021229 | CISPLATIN + GEMCITABINE |
| 290006887 | 290005231 | 1.8 | 71 | Curative (C) | 2017-02-12 | 2017-02-13 | Cisplatin 7 day | N | N | 290021229 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290006888 | 290005231 | null | 102.2 | Palliative (P) | 2014-04-25 | 2014-05-11 | Cisplatin + Fluorouracil + RT 5day | N | null | 290021229 | PEMBROLIZUMAB |
| 290006889 | 290005231 | 1.56 | 73 | Adjuvant (A) | 2015-07-05 | 2015-07-19 | Olaratumab | N | Y | 290021229 | CARBOPLATIN + RT |
| 290006890 | 290005232 | 1.62 | 71.5 | Palliative (P) | 2015-04-22 | 2015-05-31 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 290021235 | SUNITINIB |
| 290006891 | 290005233 | 1.68 | null | Palliative (P) | 2014-02-03 | 2014-03-03 | Folfirinox | null | N | 290021240 | DOCETAXEL |
| 290006892 | 290005234 | 1.7 | 93 | Neo-adjuvant (N) | 2015-02-20 | 2015-02-20 | Bortezomib (weekly) | 2 | N | 290021241 | CISPLATIN |
| 290006893 | 290005234 | 1.73 | 67 | Neo-adjuvant (N) | 2015-08-11 | 2015-08-25 | Capecitabine + Oxaliplatin 21day | 2 | null | 290021241 | CAPECITABINE + RT |
| 290006894 | 290008002 | 1.66 | 58.1 | Disease modification (D) | 2016-06-27 | 2016-07-14 | FLUOROURACIL + MITOMYCIN | N | N | 290021246 | OCTREOTIDE |
| 290006895 | 290005235 | 1.68 | 70.7 | Palliative (P) | 2015-01-24 | 2015-01-29 | Fluorouracil PVI + Mitomycin 42 day | 2 | N | 290021246 | CAPECITABINE |
| 290006896 | 290005237 | 1.82 | 80.8 | Adjuvant (A) | 2013-07-27 | 2013-07-27 | LANREOTIDE | 02 | N | 290021250 | TRASTUZUMAB |
| 290006897 | 290005237 | null | 78.2 | Palliative (P) | 2014-11-16 | 2014-12-13 | null | 02 | N | 290021250 | CAPECITABINE + CISPLATIN |
| 290006898 | 290005237 | 1.64 | 50.4 | Curative (C) | 2013-12-16 | 2013-12-30 | LANREOTIDE | 2 | N | 290021250 | R-EPOCH |
| 290006899 | 290005238 | 1.6 | 59.3 | Curative (C) | 2015-08-07 | 2015-08-07 | OCTREOTIDE | 2 | N | 290021259 | CISPLATIN + RT |
| 290006900 | 290005239 | 1.47 | null | Adjuvant (A) | 2017-06-07 | 2017-06-07 | CETUXIMAB + RT | null | N | 290021270 | CISPLATIN + RT |
| 290006901 | 290005240 | null | 83.6 | Curative (C) | 2015-02-26 | 2016-04-08 | Docetaxel | 02 | N | 290021271 | FLUOROURACIL + MITOMYCIN |
| 290006902 | 290005241 | 1.9 | 84.6 | Palliative (P) | 2014-06-25 | 2014-07-01 | Cisplatin + Radiotherapy | 2 | N | 290021273 | OCTREOTIDE |
| 290006903 | 290007215 | 1.59 | null | Disease modification (D) | 2017-09-12 | 2018-04-25 | CARBOPLATIN + ETOPOSIDE | N | N | 290021275 | FLUOROURACIL + MITOMYCIN |
| 290006904 | 290005242 | 1.87 | 80.7 | Palliative (P) | 2015-07-25 | 2015-07-25 | CETUXIMAB | null | N | 290021277 | CAPECITABINE |
| 290006905 | 290005244 | null | 128.999 | Curative (C) | 2015-08-21 | 2015-10-02 | Irinotecan | 02 | null | 290021281 | CISPLATIN + RT |
| 290006907 | 290005247 | 1.78 | 67.6 | Palliative (P) | null | 2017-07-28 | CETUXIMAB + RT | null | N | 290021286 | CETUXIMAB + IRINOTECAN + MDG |
| 290006908 | 290005248 | 1.77 | 65.1 | Neo-adjuvant (N) | 2013-04-16 | 2013-04-30 | NIVOLUMAB | N | N | 290021289 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290006909 | 290005248 | 1.73 | null | Curative (C) | null | 2017-08-23 | Capecitabine + Mitomycin | null | null | 290021289 | FLUOROURACIL + MITOMYCIN |
| 290006910 | 290005249 | 1.63 | 78.9 | Curative (C) | 2015-09-13 | 2015-10-05 | MCX | N | N | 290021292 | FLUOROURACIL + MITOMYCIN |
| 290006911 | 290005250 | 1.64 | 84.25 | null | 2016-11-16 | 2017-02-10 | BCG Intravesical | N | null | 290021292 | CARBOPLATIN |
| 290006912 | 290005250 | 1.7 | null | Palliative (P) | null | 2017-05-04 | Cetuximab + CISPLATIN + FLUOROURACIL | 2 | Y | 290021292 | ERLOTINIB |
| 290006913 | 290005250 | 1.65 | null | Not known (9) | null | 2015-11-17 | Trastuzumab + VINORELBINE | N | N | 290021292 | CARBOPLATIN + ETOPOSIDE |
| 290006914 | 290008460 | 1.78 | null | Palliative (P) | 2015-03-10 | 2015-04-06 | Carboplatin AUC 2 - 5 | N | null | 290021304 | CAPECITABINE + CISPLATIN |
| 290006915 | 290005253 | 1.65 | 86.7 | null | 2019-03-30 | 2019-03-30 | Ipilimumab | N | N | 290021312 | CARBOPLATIN |
| 290006916 | 290005254 | 1.66 | 72.7 | Curative (C) | 2016-05-15 | 2016-05-15 | CHOP R - 21 days | N | N | 290021315 | NOT MATCHED |
| 290006917 | 290005254 | 1.76 | 113 | Adjuvant (A) | 2016-12-13 | 2016-12-13 | Cisplatin 7 day | N | Y | 290021315 | CAPECITABINE + OXALIPLATIN |
| 290006918 | 290005254 | 1.66 | 54.5 | Curative (C) | 2015-11-21 | 2015-11-23 | Capecitabine + Oxaliplatin 21day | N | N | 290021315 | ETOPOSIDE + IFOSFAMIDE |
| 290006919 | 290005255 | 1.46 | 41.6 | Curative (C) | 2014-07-16 | 2014-07-29 | CAV | null | N | 290021325 | CARBOPLATIN + RT |
| 290006920 | 290005256 | 1.8 | 53.6 | Palliative (P) | 2015-12-14 | 2015-12-14 | LANREOTIDE | N | N | 290021332 | CAPECITABINE + OXALIPLATIN |
| 290006921 | 290005257 | null | 48 | Disease modification (D) | 2014-12-31 | 2014-12-31 | Capecitabine | N | N | 290021334 | BORTEZOMIB + THALIDOMIDE |
| 290006922 | 290005257 | 1.58 | null | Curative (C) | 2014-02-26 | 2015-08-05 | FLUOROURACIL + MITOMYCIN | N | Y | 290021334 | CAPECITABINE + MITOMYCIN |
| 290006923 | 290005258 | 1.63 | 48.2 | Disease modification (D) | 2017-07-15 | 2017-09-24 | Capecitabine | N | N | 290021338 | RITUXIMAB |
| 290006924 | 290005258 | 1.76 | 71 | Curative (C) | 2018-07-03 | 2019-05-04 | CAPECITABINE + OXALIPLATIN | N | N | 290021338 | CISPLATIN |
| 290006925 | 290005258 | 1.62 | 105 | Palliative (P) | 2016-07-24 | 2016-08-20 | CAPECITABINE + OXALIPLATIN | 2 | null | 290021338 | CAPECITABINE |
| 290006926 | 290005259 | 1.73 | 104.7 | Curative (C) | 2016-12-05 | 2016-12-14 | MCX | N | Y | 290021347 | CISPLATIN |
| 290006927 | 290005260 | 0 | 86 | Not known (9) | 2016-12-11 | 2016-12-14 | PEMBROLIZUMAB | N | N | 290021359 | CISPLATIN + RT |
| 290006928 | 290005261 | 1.56 | null | Palliative (P) | 2015-02-22 | 2015-03-11 | Cetuximab 7 day (>Cycle 2) | 2 | N | 290021369 | CARBOPLATIN |
| 290006929 | 290005262 | 1.77 | 113 | Palliative (P) | 2018-06-06 | 2018-06-25 | CETUXIMAB + RT | N | N | 290021371 | LANREOTIDE |
| 290006930 | 290005263 | 1.77 | 44 | Curative (C) | 2017-12-28 | 2017-12-29 | TEMOZOLOMIDE | N | N | 290021387 | CETUXIMAB |
| 290006931 | 290005264 | 1.71 | 60.4 | Disease modification (D) | 2015-10-19 | 2016-03-14 | FLUOROURACIL + MITOMYCIN | null | N | 290021387 | DA |
| 290006932 | 290007227 | 1.75 | 85.7 | Palliative (P) | 2017-03-07 | 2017-03-07 | INTERAACT trial | N | N | 290021391 | TRABECTEDIN |
| 290006933 | 290007227 | 1.73 | 67 | Palliative (P) | 2017-12-10 | 2017-12-17 | Capecitabine (14 days)+Carboplatin | N | N | 290021391 | CAPECITABINE |
| 290006934 | 290005270 | 1.78 | 75.8 | Palliative (P) | 2017-10-17 | 2017-10-20 | Capecitabine | N | N | 290021398 | TRASTUZUMAB + VINORELBINE |